Cargando…

Thromboprophylaxis and clinical outcomes in moderate COVID-19 patients: A comparative study

BACKGROUND: Many thrombotic complications are linked to coronavirus disease 2019 (COVID-19). Antithrombotic treatments are important for prophylaxis against these thrombotic events. OBJECTIVES: This study was designed to compare enoxaparin and rivaroxaban as prophylactic anticoagulants in moderate c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohamed, Asmaa S., Ahmad, Hosam M., Abdul-Raheem, Alyaa S.A., Kamel, Fatma M.M., Khames, Ali, Mady, Ahmed F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288247/ https://www.ncbi.nlm.nih.gov/pubmed/35864037 http://dx.doi.org/10.1016/j.sapharm.2022.07.004

Ejemplares similares

Thromboprophylaxis in Patients Admitted to the Surgical Ward: Clinical Audit
por: Abdalla, Yassin Abdelrahim, et al.
Publicado: (2023)

Thromboprophylaxis after bariatric surgery
por: Almarshad, Feras M., et al.
Publicado: (2020)

Venous Thromboprophylaxis in Spine Surgery
por: Alvarado, Anthony M., et al.
Publicado: (2019)

Thromboprophylaxis in Intensive Care Unit Patients: A Literature Review
por: Ejaz, Amna, et al.
Publicado: (2018)

Thromboprophylaxis in critical care
por: Helms, Julie, et al.
Publicado: (2022)

Simplifying Thromboprophylaxis Could Improve Outcomes in Orthopaedic Surgery
por: Friedman, Richard J.
Publicado: (2010)

Is thromboprophylaxis effective in reducing the pulmonary thromboembolism?
por: Rajabi, Fereshteh, et al.
Publicado: (2012)

Outcomes following pancreatic surgery using three different thromboprophylaxis regimens
por: Hanna‐Sawires, R. G., et al.
Publicado: (2019)

Comparing Australian orthopaedic surgeons’ reported use of thromboprophylaxis following arthroplasty in 2012 and 2017
por: Mirkazemi, Corinne, et al.
Publicado: (2019)

Outcomes of thromboprophylaxis with enoxaparin vs. unfractionated heparin in medical inpatients
por: McGarry, Lisa J, et al.
Publicado: (2006)

Heparin thromboprophylaxis in critically ill patients: Is it really changing outcome?
por: Gurjar, Mohan
Publicado: (2014)

Obstetric Thromboprophylaxis: The Swedish Guidelines
por: Lindqvist, Pelle G., et al.
Publicado: (2011)

Pharmacological thromboprophylaxis and epidural anaesthesia
por: Harsoor, SS, et al.
Publicado: (2012)

Thromboprophylaxis in routine arthroscopy of knee
por: Abouali, Jihad, et al.
Publicado: (2013)

Thromboprophylaxis for Total Knee Arthroplasty
por: Gali, Julio Cesar, et al.
Publicado: (2019)

Thromboprophylaxis for medical inpatients with coronavirus disease 2019
por: Dalager-Pedersen, M., et al.
Publicado: (2020)

Some genetic differences in patients with rheumatoid arthritis
por: Ahmad, Hosam M., et al.
Publicado: (2023)

Biochemical markers and FokI and TaqI vitamin D receptor genes polymorphism in rheumatoid arthritis
por: Ahmad, Hosam M., et al.
Publicado: (2023)

Efficacy and Safety of Thromboprophylaxis Post-Orthopedic Surgery
por: Alsheikh, Khalid, et al.
Publicado: (2021)

Renal function and thromboprophylaxis in critically ill patients
por: Scholey, Gareth M, et al.
Publicado: (2010)

Anti-Xa Directed Thromboprophylaxis in Critically Ill Patients with Coronavirus Disease 2019
por: Mohamed, Adham, et al.
Publicado: (2022)

Characterizing the delays in adequate thromboprophylaxis after TBI
por: Dhillon, Navpreet K, et al.
Publicado: (2021)

Does High-Dose Thromboprophylaxis Improve Outcomes in COVID-19 Patients? A Meta-analysis of Comparative Studies
por: Elsebaie, Maha A. T., et al.
Publicado: (2022)

Postcesarean Thromboprophylaxis with Two Different Regimens of Bemiparin
por: Cruz, Milagros, et al.
Publicado: (2011)

Therapeutic Impacts of Hyperbaric Oxygen Therapy and Risperidone on Children with Autism: A Clinical Trial
por: Mohamed, Asmaa S, et al.
Publicado: (2023)

Adequate thromboprophylaxis in critically ill patients
por: Levi, Marcel
Publicado: (2010)

Thromboprophylaxis in spinal surgery: a survey
por: Bryson, David J, et al.
Publicado: (2012)

Perioperative thromboprophylaxis in liver transplant patients
por: De Pietri, Lesley, et al.
Publicado: (2018)

Stroke and Thromboprophylaxis in the Era of COVID-19
por: Ma, Alice, et al.
Publicado: (2021)

Coagulation abnormalities & thromboprophylaxis in COVID-19
por: Jandial, Aditya, et al.
Publicado: (2021)

Thromboprophylaxis in COVID-19 – Rationale and considerations
por: Bristogiannis, Sotirios, et al.
Publicado: (2021)

Aspirin thromboprophylaxis in joint replacement surgery
por: Sharda, Anish V., et al.
Publicado: (2022)

Extended Thromboprophylaxis in Patients with COVID-19
por: Zhao, Wei, et al.
Publicado: (2021)

Thromboprophylaxis strategies for COVID-19 patients
por: Porres-Aguilar, Mateo, et al.
Publicado: (2022)

Thromboprophylaxis in Intramedullary Limb Lengthening Surgery
por: Iliadis, Alexios D, et al.
Publicado: (2020)

Thromboprophylaxis in Patients With Cancer and COVID-19
por: Lecumberri, Ramón, et al.
Publicado: (2022)

Overuse and underuse of thromboprophylaxis in medical inpatients
por: Kocher, Barbara, et al.
Publicado: (2023)

Thromboprophylaxis in hospitalized and nonhospitalized medical patients: what’s new?
por: Rezende, Suely M., et al.
Publicado: (2023)

American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis
por: Cuker, Adam, et al.
Publicado: (2022)

Anti-FXa Activity with Intermediate-Dose Thromboprophylaxis in COVID-19
por: Rappaport, Stephen H., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m45uc8diftit1kiacck4obffih